ASTRO members receive fellows designation
American Society for Radiation Oncology selected 27 members to receive ASTRO fellow designation.
The honorees will be recognized during a ceremony at ASTRO Annual Meeting, scheduled for Oct. 23-26 in San Antonio.
ASTRO fellow designation honors individuals who made significant contributions to the society and radiation oncology through research, patient care, education or service to the field. Only 421 of ASTRO’s 10,000-plus members around the world have received FASTRO designation since 2006.
“On behalf of ASTRO, I commend these outstanding physicians and scientists for their far-reaching contributions to radiation oncology, including their leadership in advancing cancer research, education and clinical care to improve patient outcomes,” Laura A. Dawson, MD, FASTRO, chair of ASTRO board of directors, said in a press release.
The 2022 fellows are Mark K. Buyyounouski, MD, MS, of Stanford University; Daniel T. Chang, MD, of Stanford University; Bhishamjit S. Chera, MD, of Medical University of South Carolina; Deborah E. Citrin, MD, of NCI; Thomas Dilling, MD, of Moffitt Cancer Center; Suzanne Evans, MD, of Yale University; Steven J. Frank, MD, of The University of Texas MD Anderson Cancer Center; Alan C. Hartford, MD, PhD, of Geisel School of Medicine at Dartmouth Health; Karen Hoffman, MD, of The University of Texas MD Anderson Cancer Center; Randall J. Kimple, MD, PhD, of University of Wisconsin-Madison; Bridget F. Koontz, MD, of GenesisCare US; Alexander Lin, MD, of University of Pennsylvania; Douglas Martin, MD, of The Ohio State University Wexner Medical Center; Charles Mayo, PhD, of University of Michigan; Michael T. Milano, MD, PhD, of University of Rochester; Eduardo Moros, PhD, of Moffitt Cancer Center; Firas Mourtada, PhD, of Sidney Kimmel Medical College at Thomas Jefferson University; Paul Nguyen, MD, of Dana-Farber Cancer Institute; Peter Orio, DO, MS, of Dana-Farber Brigham Cancer Center; William F. Regine, MD, of University of Maryland School of Medicine; Peter J. Rossi, MD, of Calaway Young Cancer Center at Valley View Hospital; Scott Soltys, MD, of Stanford University; Roy Tishler, MD, PhD, of Dana-Farber Cancer Institute; Minh Tam Truong, MD, MBBS, of Boston University School of Medicine; Richard Tsang, MD, of Princess Margaret Cancer Centre; Jonathan Tward, MD, PhD, of Huntsman Cancer Institute at University of Utah; and Fen Xia, MD, PhD, of University of Arkansas for Medical Sciences.